Surmodics, Inc. (SRDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.34+0.34 (+0.89%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 38.00 |
| Open | 37.63 |
| Bid | 28.55 x 1200 |
| Ask | 40.55 x 800 |
| Day's Range | 37.63 - 38.64 |
| 52 Week Range | 22.06 - 49.00 |
| Volume | 55,985 |
| Avg. Volume | 53,810 |
| Market Cap | 523.349M |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | 68.46 |
| EPS (TTM) | 0.56 |
| Earnings Date | Aug 05, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 64.25 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-38% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Business Wire
Surmodics Receives FDA 510(k) Clearance for Pounce™ Thrombus Retrieval System
Surmodics announced it receives FDA 510(k) Clearance for Pounce™ Thrombus Retrieval System.
- Zacks
Here's Why You Should Add Surmodics to Your Portfolio Now
Investor confidence is high on Surmodics (SRDX) stock, thanks to solid prospects.
- Zacks
Why Is SurModics (SRDX) Down 7.3% Since Last Earnings Report?
SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2020 Verizon Media. All rights reserved.
